Boc-L-aspartic acid α-N-hydroxysuccinimide ester

Boc-L-aspartic acid α-N-hydroxysuccinimide ester is a protected L-aspartic acid derivative in which the alpha-amino group is masked as a Boc carbamate and the carboxyl functionality is converted into an activated N-hydroxysuccinimide (NHS) ester. This combination makes the molecule a practical amino acid building block for coupling reactions, while the Boc group supports controlled handling and downstream peptide or intermediate synthesis workflows. In chemical biology and materials chemistry, NHS-activated amino acid derivatives are commonly selected to enable efficient amide-bond formation under mild conditions with nucleophiles such as primary amines.

1. Peptide Coupling Building Block

Boc-L-aspartic acid α-N-hydroxysuccinimide ester is used by peptide chemistry groups to introduce an aspartyl unit into peptide segments and aspartate-containing intermediates via NHS-mediated acyl transfer to amine-bearing partners. The activated ester format supports rapid formation of amide bonds with amino-functionalized substrates, which is particularly useful when assembling short peptides, peptide fragments, or aspartate-containing linkers prior to final deprotection and coupling steps. The presence of the Boc-protecting group on the amino functionality helps maintain compatibility with standard peptide synthesis workflows where orthogonal protection and controlled deprotection timing are important for sequence fidelity.

2. Bioconjugation Linker Synthesis

Boc-L-aspartic acid α-N-hydroxysuccinimide ester is applied in bioconjugation development to prepare aspartate-based linkers and amide-linked conjugates where an NHS-activated carboxyl group is required for efficient coupling to primary amines on biomolecules or biomolecule-mimicking scaffolds. Researchers in chemical biology and biomaterials commonly use this type of activated amino acid derivative to generate defined amide connections for conjugate libraries, surface immobilization precursors, and reagent building blocks that later undergo deprotection or further functionalization. The aspartate side-chain provides a chemically meaningful handle for designing conjugation architectures that preserve the desired spacing and polarity in the final construct.

3. Pharmaceutical Intermediate Development

Boc-L-aspartic acid α-N-hydroxysuccinimide ester is used by medicinal chemistry and process development teams as an activated amino acid intermediate for constructing amide-containing motifs that incorporate an aspartate-derived fragment. The NHS ester enables straightforward coupling to amine nucleophiles during synthesis planning for peptidomimetic scaffolds, linker units, and heteroamide intermediates that require reliable formation of the C(O)-N bond. The Boc protection pattern supports controlled downstream transformations, allowing the derivative to be carried through intermediate stages where selective unmasking of functional groups is required to reach the intended intermediate profile.

4. Analytical Reference Derivative Preparation

Boc-L-aspartic acid α-N-hydroxysuccinimide ester is also employed in analytical chemistry workflows to generate defined amide products and standards used for method development and characterization of coupling chemistry. Laboratories developing LC-MS or HPLC methods for activated ester reactivity, conjugate formation, or stability studies often rely on well-defined amino acid-derived NHS intermediates to benchmark conversion and identify expected product mass/fragmentation patterns. Because the derivative contains both a protected amino group and an activated carboxyl functionality, it serves as a practical reference material for verifying the performance of amide coupling steps in synthetic and bioconjugation protocols.

1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

4. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

5. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides